Singular Health Group Ltd Cash Flow Conversion Efficiency
Singular Health Group Ltd cash flow conversion efficiency. Based on the latest financial reports, Singular Health Group Ltd (SHG) has a cash flow conversion efficiency ratio of -0.266x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.11 Million ≈ $-2.20 Million USD) by net assets (AU$11.69 Million ≈ $8.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Singular Health Group Ltd (2019–2024)
Cash flow conversion efficiency of Singular Health Group Ltd from 2019 to 2024. This chart illustrates how Singular Health Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SHG stock price and chart for real-time trading data and today's change.
Singular Health Group Ltd Cash Flow Conversion Ratio Explained
Singular Health Group Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Singular Health Group Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Singular Health Group Ltd ranked by their cash flow conversion efficiency. Also see SHG market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lunnon Metals Ltd
AU:LM8
|
-0.119x |
|
BE Group AB
ST:BEGR
|
-0.005x |
|
Sukhjit Starch & Chemicals Limited
NSE:SUKHJITS
|
-0.146x |
|
Bina Puri Holdings Bhd
KLSE:5932
|
-0.332x |
|
Emperor Energy Ltd
AU:EMP
|
-0.062x |
|
GenoFocus Inc
KQ:187420
|
-0.015x |
|
SVOA Public Company Limited
BK:SVOA
|
0.046x |
|
The Beachbody Company, Inc.
NYSE:BODI
|
0.159x |
Annual Cash Flow Conversion Efficiency for Singular Health Group Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Singular Health Group Ltd from 2019 to 2024. Review SHG cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$13.10 Million ≈ $9.27 Million |
AU$-2.34 Million ≈ $-1.66 Million |
-0.179x | +89.44% |
| 2023-12-31 | AU$1.44 Million ≈ $1.02 Million |
AU$-2.44 Million ≈ $-1.73 Million |
-1.693x | +95.75% |
| 2022-12-31 | AU$61.89K ≈ $43.79K |
AU$-2.46 Million ≈ $-1.74 Million |
-39.798x | -2295.06% |
| 2021-12-31 | AU$1.75 Million ≈ $1.24 Million |
AU$-2.91 Million ≈ $-2.06 Million |
-1.662x | -342.81% |
| 2020-12-31 | AU$5.08 Million ≈ $3.60 Million |
AU$-1.91 Million ≈ $-1.35 Million |
-0.375x | -114.62% |
| 2019-12-31 | AU$-213.59K ≈ $-151.13K |
AU$-548.17K ≈ $-387.86K |
2.567x | -- |
About Singular Health Group Ltd
Singular Health Group Ltd, a medical technology company, engages in the development and provision of 3DiCom software medical technology in Australia. The company offers volumetric rendering platform which converts 2D medical images into interactive 3D volumetric models for use in visualization, understanding, diagnosis, and treatment planning. It also provides medical file transfer protocol for f… Read more